L-R near Tache MB (35 Result(s))

Structure Monitoring Technology Ltd. or SMT, designs software and electronics used to monitor and evaluate the integrity and performance of commercial and residential buildings. Real-time sensor analysis and remote data collection have allowed Engineers and Researchers to validate designs, materials and methods to produce more efficient & durable buildings, reducing their environmental impact while improving quality assurance throughout the construction and/or restoration process. Founded in 2006, SMT has expanded to include low & high value building projects throughout the world. SMT fosters award winning innovation and scientific excellence in both our product lines and services as well as in our commitment to customers, clients, & researchers.SMT has deployed systems across North America ranging from simple wood frame homes, to glass and steel skyscrapers, shopping centers, heritage buildings, art museums, data centers, and national research labs. The Building Intelligence platform addresses the need for automated remote data collection with analytics of building performance trends/events.

We're your source for everything Ford in Mid-Town Ford, from Sales & Service to Parts. Give us a call or stop by to find your perfect vehicle, or for anything you need on the one you already have.

Murray Chevrolet is a dealership in Winnipeg, MB, specializing in the sale of new and used Chevrolet vehicles, offering comprehensive services including financing, maintenance, and collision repair.

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.